Warren Buffet said that patience was the key to making

New Post Public Reply Private Reply Replies (2) Message Board
lchase01
Warren Buffet said that patience was the key to making money with stocks.  It is emotion and impatience that is the downfall.  I learned the hard way some of these lessons:

1.  Don't invest more than you can afford to lose.  The market is a gamble, no matter what anyone says.  There are no sure bets whatsoever.  

2.  You don't lose money until you sell.  On the "other" board, the bashers always try to play the emotion game by telling everyone how much money they've lost. You haven't lost anything unless you choose to do so.  The only exception is if the company goes belly up, bankrupts and moves out of bankruptcy to new issuance of shares or is a scam with no chance of ever coming back.  There was a time that Apple was selling in the 100's and then a few months later, even after a stock split, was selling in the teens.  I'm sure people were crying all over the place that they lost so much money.  Hang on to the stock and ten years later, after two more stock splits, it's selling in the 700's.  Patience!

3.  Do your own research, rely on no one else.  If folks are scanning the message boards to see what the next stock to invest in, they're already lost.  People lie, dissemble, mislead and bash.  The next day, the same people have done a complete 180.  Make up your own mind based on your own knowledge and trust.

4.  Wait it out.  SNDY is a pinkie.  Yes, the company saw some bad times and, yes, there were reverse splits, there was and is dilution, etc.  That's not the end of the chapter.  There's a lot more.  The company has a plan, is carrying through with it, has good products that are real, and is working with solid companies like Emergo.  Solid footings.

5.  Don't be greedy.  Not everyone hits the stock that goes 1,000% in just a day, year or even a decade.  Keep things in perspective.  If you double your money, you've done very well.  Tripled it?  Kudos to you.  

6.  Long term capital gains taxes are significantly cheaper than short term.  Keep a record of your buys, when and how much.  A spiral notebook you buy at the dollar store and a bic pen can save you a lot of money.

7.  But it and forget it.  Day to day fluctuations can wear on your nerves.  Add to that the message board bashers who scream that the world is ending just because the stock went down from .004 to .0035.  That's only 5/1,000 of a penny! World over?  No.

8.  Slow and steady is better than fast and wobbly.  I would rather see the stock raise a little every week over a year's time to go from .0008 to .008 than overnight.  It keeps the flippers away (they're always impatient) and it speaks to a solid investment.

9.  Never bank on the next PR to be the PR.  It won't be.  It'll help, but it won't be the golden goose.  

10.  Take deep breaths and walk away from the computer.  Go take a walk, watch a movie, take a power nap, eat a cookie and pet the dog.  Obsessive watching of the stock never helps the stock and won't help you.

11.  Don't try to buy at the very bottom and never try to guess what the very top will be.  You'll rarely, if ever, get it right.  If the stock price is going down and you see it at 4 cents and you like that price, then buy it.  So it goes down to 1 cent and you kick yourself…if you don't sell, you haven't lost anything.  It then goes up and you sell it at 12 cents (tripled your money) and then you see it hit 20 cents.  You stay up all night wishing you would have sold at 20 cents.  Guess what!  You may not have been able to sell there, there may not have been a lot of buyers there. The ones who bought your shares didn't triple their dollars, like you did.  

Always work out your entrance and exit strategies ahead of time and stick to them, with happiness.  Yes, you could have made some more money, but you might have also lost a lot more as well.

Lastly, good luck.  Things are good for us and, as Mike says, we need to wait.

CYduct Diagnostics Inc. (CYDX) Stock Research Links

CYDX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

PARRIS Law Firm Triumphs in Landmark Billing Case Against Edison

Updated Category News Views 258

PARRIS Law Firm Achieves Major Victory in Consumer Lawsuit The PARRIS Law Firm has recently celebrated a significant win for consumers in a landmark lawsuit against Southern California Edison Company. This case, referencing the Wellman v. Southern California Edison Company, has captured media attention, notably from The Daily Journal, showcasing the firm’s commitment to...

Continue Reading
Intercont (Cayman) Limited's Growth: Exploring Recent Financials

Updated Category News Views 112

Intercont (Cayman) Limited Unveils Financial Results Intercont (Cayman) Limited (NASDAQ: NCT), a prominent leader in the global shipping industry, has shared its financial results for the first half of the fiscal year. The company, renowned for its innovative approach to seaborne pulping operations, reported notable advancements in its financial performance, reflecting...

Continue Reading
What to Expect from Quanex Building Products' Earnings Report

Updated Category News Views 107

Understanding the Upcoming Earnings of Quanex Building Products Quanex Building Products (NASDAQ: NX) is gearing up to announce its quarterly earnings. This moment has been highly anticipated by investors eager to gain insights into the company's financial health. While specific dates are typically essential to focus on, the critical takeaway for investors is the...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 18

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Innovative Cancer Treatments: CMU and Healthcare System Lead the Way

Updated Category News Views 266

Revolutionizing Cancer Treatment China Medical University (CMU) and Healthcare System are making significant strides in the field of cancer treatment, notably through AI-driven drug discovery and innovative therapies. At a recent healthcare exposition, these organizations showcased their leading-edge advancements, establishing themselves as pioneers in healthcare...

Continue Reading